Gene Query: MPP5

Dataset Description Geneva Score
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 42.6
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 36.12
Crizotinib v. DMSO in SW480 cells 34.35
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 33.77
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 26.31
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 26.31
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 25.89
Functional role of CPPED1 in trophoblasts. 25.85
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 23.28
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 21.99
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 21.99
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 21.9
mRNA-Seq profiling of human developing kidney 21.89
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 21.64
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 21.21
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 21.05
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 21.04
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 20.78
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 20.78
Genome wide expression change by RNF168 knocking down in MCF-7 cells 20.28
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 19.85
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 19.3
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 18.77
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 18.68
MYCi975 regulates MYC target genes 18.64
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 18.63
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 18.47
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 18.1
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 17.43
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 17.05
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 17.05
Inhibition of TNBC metastasis by Gpx1 16.88
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 16.27
Ebola virus (EBOV) infection of ARPE-19 cells 15.95
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 15.58
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 15.57
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 15.44
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 15.1
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 15.09
Nucleoporin-mediated regulation of cell identity genes 15.03
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 15.0
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 14.94
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 14.76
TFAP2C signalling in human fibroblasts 14.68
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 14.12
Ribosomal footprinting of CN34-Parental and CN34-LM1a 14.09
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 13.81
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 13.29
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 12.9
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 12.9
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.82
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 12.78
Lineage specific differentiation is influenced by state of human pluripotency 12.78
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 12.5
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 12.4
Transcriptome-wide response to synthetic chromatin protein PcTF 12.2
Genome wide expression change by RNF168 knocking down in NEC cells 12.16
RNA-seq of cells with TET1 knockout 12.11
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 11.95
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 11.61
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 11.54
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 11.54
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 11.54
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 11.54
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 11.11
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 11.06
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 11.05
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 10.77
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 10.77
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 10.74
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 10.58
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 10.57
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 10.57
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 10.52
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 10.45
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.44
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.44
Expression level comparison under dividing and quiescent states in human primary fibroblasts 10.3
RNA-seq analysis of the human fetal kidney. 10.27
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 10.27
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 10.17
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 10.15
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 10.14
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 10.08
RNA-seq analyses of human prostate cancer cells 10.04
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 9.99
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 9.97
Selective expression of long non-coding RNAs in a breast cancer cell progression model 9.93
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 9.84
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 9.84
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 9.67
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 9.67
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 9.53
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 9.46
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 9.42
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.4
hTERT promotes cell adhesion and migration independent of telomerase activity 9.37
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 9.29
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.24
Genes significantly down or Up-regulated upon RNF219 knockdown 9.23
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 9.12
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 9.09
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 9.05
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 9.02
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 9.01
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 8.94
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 8.86
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 8.85
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 8.85
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 8.83
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 8.79
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.74
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 8.73
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 8.69
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 8.65
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 8.64
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 8.63
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 8.63
Effect of PBK knockdown on C4-2 cell transcriptome 8.58
Disruption of the exocyst induces podocyte loss and dysfunction 8.48
Noncoding regions are the main source of targetable tumor-specific antigens 8.44
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.43
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 8.42
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 8.35
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 8.34
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 8.34
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 8.32
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 8.3
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 8.29
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 8.27
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 8.27
RNA-seq of young and quiescent MRC-5 human fibroblasts 8.27
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 8.22
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 8.22
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 8.22
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 8.14
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 8.11
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 8.05
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 8.04
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 8.02
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 7.96
Active translatome profiling with RiboLace in MCF7 cells 7.94
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 7.93
Global Mapping of Human RNA-RNA Interactions 7.91
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.88
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 7.81
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 7.78
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 7.77
Dtx3L and Androgen Signaling in Prostate Cancer 7.77
Effect of mitochondria deficiency on senescence-associated gene expression 7.75
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 7.7
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 7.6
Human cell line and subcutaneous tumor 7.57
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.55
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 7.51
SLIGRL-induced gene expression changes in NHEK cells 7.48
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 7.47
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 7.43
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.41
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 7.3
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.24
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 7.2
EWS-Fli and LNC regulated genes in comparison to GFP samples 7.11
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 7.09
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 7.05
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 7.04
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.94
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.93
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.93
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.93
Transcriptome profiling of 5 human adenocarcinoma cell lines 6.92
The role of FAM46C in myeloma cells 6.92
The role of FAM46C in myeloma cells [sequencing] 6.92
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 6.89
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 6.86
RNAseq Analysis in glioblastoma cells treated with Mepazine 6.85
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 6.84
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 6.83
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 6.81
HNF1 regulates critical functions of the human epididymis epithelium. 6.81
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 6.81
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 6.77
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 6.72
Conservative alteration of chromosomal expression pattern across human solid tumor types 6.72
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 6.7
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 6.65
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 6.65
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 6.61
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 6.61
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 6.6
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 6.59
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 6.57
BAF controls genome accessibility 6.57
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.56
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6.56
Transcriptomic analysis of LSD1 6.52
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 6.5
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 6.48
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 6.48
CDK12 mediated transcriptional regulation in U2OS cells 6.44
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 6.41
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.4
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 6.37
The transcriptome effect of overexpressing EZH2 in MCF7 6.36
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.35
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.35
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 6.32
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 6.28
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 6.28
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.26
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 6.24
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 6.23
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 6.22
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 6.22
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 6.22
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 6.21
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 6.2
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 6.17
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.16
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 6.16
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 6.14
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 6.13
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 6.11
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 6.1
Androgen Receptor-regulated genes in prostate cancer cells 6.06
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 6.06
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 6.05
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 6.02
Identification of Sin3B regulated genes during quiescence 5.98
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.98
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.96
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.96
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 5.94
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.93
RNA-seq analysis upon ARID1B overexpression 5.89
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 5.88
EGR1-controlled transcriptome of T HESCs 5.87
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 5.81
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 5.8
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 5.77
Gene Expression Profiling of SPOP Knocked Down Cell 5.74
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.73
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.71
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 5.69
RNA-seq of RKO cells with cTAZ KO or putback 5.64
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 5.63
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 5.63
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.63
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 5.59
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 5.55
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 5.52
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.42
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 5.39
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 5.39
Transcriptomic analyssis following EHMT1/2 inhibition 5.32
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 5.31
Aneuploidy triggers an immune response 5.31
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.29
Gene expression profile in breast cancer cells 5.29
Analysis of transcriptional regulation by Myt1 and Myt1l 5.24
EWSR1 influences alternative splicing through direct and indirect mechanisms 5.22
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 5.19
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 5.17
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 5.17
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 5.17
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 5.16
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 5.16
IL-33 activates tumor stroma to promote intestinal polyposis 5.14
RNA-Seq with and without RNase treatment in PCa cell lines 5.12
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 5.11
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 5.11
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 5.11
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 5.11
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 5.11
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 5.08
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 5.08
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 5.05
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 5.05
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 5.04
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 5.01
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 5.01
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 4.97
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.97
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.97
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 4.94
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 4.94
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 4.94
Differetially expressed genes after hTR overexpression in U2OS cells 4.94
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 4.92
Illumina Total RNA-seq in HeLa 4.91
RNA-seq analysis of control and Myc-induced U2OS cells 4.84
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.83
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 4.8
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 4.74
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 4.74
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 4.74
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.72
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 4.71
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.7
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.7
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.68
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 4.68
RNA-Seq of PRMT1 overexpression ECA109 cells 4.65
Next generation sequencing of small RNAs isolated from exosomes in human semen 4.62
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 4.62
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 4.62
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 4.53
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 4.53
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 4.49
CD73 knockdown effect in pancreatic cancer cell lines 4.48
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 4.47
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 4.42
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 4.42
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 4.42
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 4.38
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 4.38
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 4.35
Activity-dependent transcriptional changes in human neurons 4.35
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 4.26
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.26
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.26
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.2
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 4.18
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.14
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 4.14
DRB/GRO-Seq -/+ UV 4.11
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 4.1
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.1
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 4.08
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 4.07
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 4.05
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.03
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 4.03
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 3.95
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 3.89
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 3.87
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 3.84
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 3.79
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.78
Gene expression analysis upon mtDNA depletion 3.78
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.77
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.73
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.73
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.71
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 3.7
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 3.7
Genome-wide analysis of Dengue virus 2 infected cells 3.66
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.63
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.62
RNA sequencing analysis of selumetinib-resistant CRC cells lines 3.6
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 3.57
Gene expression profile of human placenta from T. Cruzi infected mothers 3.55
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 3.54
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 3.43
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 3.43
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 3.41
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.4
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.39
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.34
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.33
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.29
Common inflammatory pathways between NEC and Crohn's disease 3.26
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 3.26
MRTF activates TEAD-YAP target gene expression 3.23
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.21
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.16
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.16
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 3.14
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 3.14
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.13
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.12
Single-cell analysis of human kidney organoids 3.1
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.07
Ribosome profiling upon inhibition of eIF4A 3.06
Genome-wide discovery of human splicing branchpoints [RNAse] 3.04
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.03
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.02
Effect of PRDM11 depletion in U2932 cells 3.01
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 2.99
Toxoplasma gondii infection of human retinal pigment epithelial cells 2.97
Identification of differentially expressed genes between senescence and senescence bypass cells 2.95
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.95
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 2.89
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 2.89
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 2.87
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 2.87
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.82
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.81
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.8
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.79
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.79
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.72
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.62
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 2.62
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.61
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.59
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.53
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.53
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.52
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.46
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.46
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.45
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 2.42
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 2.41
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 2.36
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 2.3
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.3
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 2.29
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.26
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.26
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.22
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.21
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.2
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.2
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.2
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 2.18
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 2.12
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.09
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.05
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.99
The circadian transcriptional landscape in primary human mammary epithelial cells 1.94
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.93
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.89
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.86
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.86
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 1.86
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.8
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.73
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.73
Effect of nuclear IL-33 on gene expression 1.6
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.55
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.54
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.53
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.51
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.48
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.48
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 1.35
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.3
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.27
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 1.19
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 1.19
Transposon-based construction of strand-specific RNA-seq libraries 1.1
hESC neural differentiation 1.08
RNA-seq analysis of gene expression patterns during hESC neural differentiation 1.08
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.01
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.0
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.96
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.96
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.96
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.96
The contribution of Alu exons to the human proteome 0.93
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.9
m6A-dependent regulation of messenger RNA stability 0.88
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.86
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.85
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.82
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.81
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.81
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.8
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.76
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.76
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.75
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.75
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.71
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.71
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.6
A code of mono-phosphorylation modulates the function of RB. 0.58
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.57
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.57
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 0.48
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.46
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.46
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.45
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.42
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.41
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.39
Gene expression of collecting duct carcinoma of the kidney 0.37
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.36
HBEC-shp53-PCHD7 0.35
MCF-7 as a model for functional analysis of breast cancer risk variants 0.33
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.3
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.27
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.27
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.26
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.24
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.24
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.23
Transcriptome-wide modulation of splicing by the exon junction complex 0.2
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.19
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.19
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 0.16
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.16
Modulation of nonsense-mediated decay by rapamycin 0.15
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.12
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.11
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.1
High-resolution comparative analysis of great ape genomes 0.08
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.05
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.05
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation